Загрузка...
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives. The European Headache Federation identified an expert group that was asked to develop...
Сохранить в:
| Опубликовано в: : | J Headache Pain |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Milan
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6755553/ https://ncbi.nlm.nih.gov/pubmed/30259200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0921-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|